8 Best Online GLP-1 Programs in 2026

What GLP-1 medications are available online — and why it matters which one you get

GLP-1 stands for glucagon-like peptide-1, a hormone your gut naturally produces after you eat. GLP-1 receptor agonist medications mimic that signal, slowing gastric emptying and reducing appetite in ways that make calorie reduction feel less like white-knuckling. Two molecules dominate the online market in 2026: semaglutide (the active ingredient in Ozempic and Wegovy) and tirzepatide (the active ingredient in Mounjaro and Zepbound).

The key difference is mechanism. Semaglutide activates one receptor — GLP-1. Tirzepatide activates two — GLP-1 and GIP. In the SURMOUNT-5 head-to-head trial published in the New England Journal of Medicine in 2025, tirzepatide produced 20.2% average body weight loss versus 13.7% with semaglutide over 72 weeks. That is a meaningful clinical gap. For most women this makes tirzepatide worth discussing with a prescriber, with the trade-off that it tends to cost more and may cause more diarrhea where semaglutide more commonly causes nausea.

Online programs may offer the branded drugs (Wegovy, Zepbound), compounded versions of those molecules, or both. The legal landscape for compounded GLP-1s shifted substantially in 2025–2026: the FDA declared the semaglutide shortage resolved in February 2025 and the tirzepatide shortage resolved in December 2024. With the shortage exception removed, 503B outsourcing facilities now face a proposed ban from bulk-compounding these drugs (the FDA's April 2026 proposal had a comment period through June 29, 2026). 503A patient-specific compounding pharmacies may still fill individual prescriptions when a prescriber documents a clear clinical reason — but mass-market compounded supply is narrowing fast.

Why midlife women have the most to gain — and why program selection matters more for them

Women between 40 and 64 have been the top recipients of GLP-1 prescriptions in the US since 2019. Perimenopause and menopause accelerate abdominal fat accumulation through declining estrogen, and that fat tends to be more metabolically active — meaning it raises cardiovascular and metabolic risk more than weight gained earlier in life.

GLP-1 medications work across menopausal status. A 2025 analysis of the SURMOUNT trial found tirzepatide produced roughly 20% body weight reduction in postmenopausal women — comparable to outcomes in premenopausal women. The more intriguing finding comes from a Mayo Clinic study published in The Lancet in 2025: postmenopausal women on tirzepatide who were also using menopausal hormone therapy lost approximately 35% more total body weight than women on tirzepatide alone. An earlier 2024 study in Menopause found the same directional synergy for semaglutide plus hormone therapy.

The working hypothesis is that estrogen enhances GLP-1 receptor sensitivity, essentially making the medication more effective. None of this means HRT is required to benefit from a GLP-1 — most women lose meaningful weight on the medication alone. But if you are on or considering hormone therapy, it is worth raising this research with your prescriber.

Mochi Health — Best Overall

Mochi Health has grown to more than 500,000 GLP-1 patients — the largest base of any telehealth weight-loss platform — and its clinical team includes physicians with board certification in obesity medicine (ABOM), a rare designation even among in-person practices. The pricing structure is unusually simple: compounded semaglutide costs $99 per month and compounded tirzepatide costs $199 per month, flat, regardless of dose. You add a $79-per-month membership on top of that. So your all-in monthly cost is $178 for semaglutide or $278 for tirzepatide — and those numbers do not climb as your titration advances.

Mochi offers compounded semaglutide in four formats: injection, oral tablet, oral drops, and microdose. The program includes 24/7 provider messaging, video visits with physicians and registered dietitians, medication management, and a patient portal. It is available in all 50 states.

• Pros: Flat pricing across all doses, ABOM-credentialed physicians, all 50 states, multiple semaglutide formats, large patient base
• Cons: Membership fee is non-refundable after 24 hours; verify current compounding pharmacy (Aequita was shut down by Washington State in March 2025); billing complaints are common on review sites

Henry Meds — Best Budget Option

Henry Meds operates as a cash-pay subscription model with no separate membership fee layered on top of medication costs. Compounded semaglutide injectable starts at around $197 per month on a 12-month prepay commitment or roughly $297 per month month-to-month. An oral semaglutide option starts at $149 per month. The all-in visit cost, medication, and supplies are bundled together.

Henry Meds is available in 41 states. Eligibility requires a BMI of 30 or higher, or 27 or higher with a qualifying comorbidity. The intake process is fully virtual, and prescriptions are delivered to your home.

• Pros: No membership fee, competitive pricing especially on annual prepay, bundled pricing makes costs predictable
• Cons: Not available in 9 states; relies on compounded GLP-1s which are in a shifting regulatory environment

Ro Body — Best for Brand-Name Medication with Labs Included

Ro made a consequential pivot in 2026: it stopped offering compounded GLP-1s entirely and moved to FDA-approved branded medications only — Wegovy (now including the oral pill approved in December 2025), Ozempic, and Zepbound. That is a principled position on the regulatory question, and it means the medication you receive has a known manufacturing chain. The trade-off is cost: the $145-per-month Ro Body membership covers provider access, lab testing through Quest Diagnostics, insurance navigation support, and 1:1 messaging — but the medication itself is additional.

At current cash prices, the oral Wegovy pill runs roughly $149 per month, injectable Wegovy around $349, and Zepbound from $299 (2.5 mg) up to $449 at higher doses. Ro also employs an insurance concierge team to help with prior authorization — since branded medications have a better shot at coverage than compounded versions, this matters.

• Pros: FDA-approved branded drugs only — clear regulatory standing; lab testing included in membership; insurance navigation support; oral Wegovy option (first GLP-1 pill approved for weight loss)
• Cons: Most expensive option at cash pay; medication costs are on top of the membership; no compounded lower-cost alternative

Eden — Best Simple Entry Point

Eden keeps onboarding straightforward: an online intake form, a provider review, and a prescription sent to a compounding pharmacy. The intro pricing is a genuine discount — $149 for the first month of compounded semaglutide, then $229 per month on a month-to-month basis. Compounded tirzepatide is $249 for the first month, then $329 per month. Eden works with both 503A and 503B compounding pharmacies, so it is worth asking which source applies to your prescription given the changing regulatory environment.

• Pros: Low intro price, straightforward intake, tirzepatide available
• Cons: Less clinical depth than Mochi or Fridays; pharmacy sourcing transparency worth verifying

Fridays — Best for Coaching-Integrated Support

Fridays bundles more lifestyle support into its fee than most competitors: physician visits, registered dietitian coaching, a fitness app, and 24/7 messaging are all included in the flat monthly price. The medication pricing is volume-tiered: compounded semaglutide runs $249 per month on a month-to-month basis, dropping to $150 per month on an annual plan. Compounded tirzepatide is $359 per month monthly or $240 per month annually. For a woman who wants accountability structure alongside the medication, Fridays is one of the most complete packages in this comparison.

• Pros: Dietitian coaching and fitness app included, microdosing available, insurance assistance for brand-name options, tirzepatide option
• Cons: Month-to-month pricing is higher than some competitors; annual commitment required for lowest rates

Hers — Best for Flexible Oral Options

Hers (the women's health arm of Hims & Hers) has notable pricing at the low end: oral compounded semaglutide starts at $69 per month. Injectable compounded semaglutide runs around $199 per month, though the lowest rates require paying six to 12 months in advance. There is no separate membership fee. Hers does not accept insurance, and labs are not included in standard plans. Hers does work with US-licensed clinicians and has broad geographic availability, making it a reasonable option for someone primarily focused on accessibility and price.

• Pros: Lowest starting price for oral semaglutide in this comparison, no membership fee, broad availability
• Cons: Labs not included; prepay required for best rates; FDA sent Hers a warning letter in September 2025 over compounded-semaglutide marketing

Noom Med — Best Behavior-Change Integration

Noom built its reputation on the psychology of eating — behavioral triggers, tracking, and habit-formation tools — and Noom Med layers GLP-1 medication on top of that infrastructure. The full-dose compounded semaglutide program is $279 per month (billed as $852 per 12-week cycle, with no mid-cycle cancellation refund). The Microdose GLP-1Rx option is $79 per month and is designed for women who want to start at a lower dose or are hesitant about side effects.

• Pros: Strong behavioral and habit-tracking tools, microdose option at $79/mo, existing Noom users can stay in one ecosystem
• Cons: No mid-cycle refund on 12-week billing; full-dose program is not the most competitive on price

Willow — Best Flat-Rate Option in Available States

Willow charges a flat monthly rate regardless of dose: $299 for compounded semaglutide, $399 for compounded tirzepatide. No membership fee, no price escalation as titration increases. The platform is LegitScript certified, posts a HIPAA notice, discloses a US address in Austin, Texas, and prescribes through Willow Medical of California, P.C. — the kind of transparency markers worth checking on any platform. The limitation is availability: Willow operates in 33 states. Willow accepts HSA and FSA payments but does not accept insurance.

• Pros: LegitScript certified, flat-rate pricing at all doses, no membership fee, accepts HSA/FSA
• Cons: Only 33 states covered; pricing is higher than Henry Meds or Eden for comparable compounded medications

What separates a legitimate program from a risky one

The FDA issued 58 warning letters in September 2025 and 30 more in March 2026 to telehealth companies for misleading marketing of compounded GLP-1 products. The violations included calling compounded semaglutide 'generic Ozempic,' implying it was FDA-approved, and using semaglutide salt forms (semaglutide sodium, semaglutide acetate) that are chemically different from the active ingredient in approved drugs.

• The intake is a questionnaire only, with no real provider interaction before the prescription is issued
• The pharmacy is not named, cannot produce a Certificate of Analysis, or is located outside the US
• The company uses the terms 'generic Wegovy,' 'same as Ozempic,' or 'FDA-approved compound' — none of these are accurate
• Pricing is suspiciously below $100 per month for injectable semaglutide without a clear explanation of the compounding source
• No follow-up care, dose adjustment support, or pathway to escalate concerns to a clinician

How to choose: a practical decision tree

• Want tirzepatide at the lowest consistent monthly cost with nationwide availability → Mochi Health ($278/mo all-in)
• Want semaglutide at the lowest monthly cost without a separate membership fee → Henry Meds (from ~$197/mo on annual plan)
• Want brand-name Wegovy or Zepbound, labs included, and insurance support → Ro Body
• Want coaching, dietitian access, and fitness support built into the fee → Fridays
• Want the absolute lowest starting price on oral semaglutide → Hers ($69/mo oral)
• Already use Noom's behavioral app and want to add medication → Noom Med
• Want LegitScript-certified flat-rate pricing and are in one of 33 states → Willow
• Want a low intro price with a straightforward intake → Eden